4//SEC Filing
Francisco David 4
Accession 0001661181-21-000035
CIK 0001661181other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:58 PM ET
Size
7.1 KB
Accession
0001661181-21-000035
Insider Transaction Report
Form 4
Francisco David
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2021-02-16+10,965→ 16,361 total - Award
Stock Option (Right to Buy)
2021-02-16+83,955→ 83,955 totalExercise: $13.68Exp: 2031-02-16→ Class A Common Stock (83,955 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 16, 2021.
- [F2]The option becomes exercisable in equal annual installments over four years beginning February 16, 2021.
Documents
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Entity typeother
Related Parties
1- filerCIK 0001846282
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:58 PM ET
- Size
- 7.1 KB